KMX
48
-7
MPC
44
2
SYK
48
2
R
67
-3
CTAS
64
2
CVX
29
-3
IFF
48
3
PFG
43
-2
KMB
51
-2
LMT
62
3
WEC
70
5
DVN
22
-3
UPS
41
11
GM
71
6
HBI
61
11
VRSK
70
-3
AMGN
39
5
NEE
60
6
CAH
69
2
MCD
41
2
KMX
48
-7
MPC
44
2
SYK
48
2
R
67
-3
CTAS
64
2
CVX
29
-3
IFF
48
3
PFG
43
-2
KMB
51
-2
LMT
62
3
WEC
70
5
DVN
22
-3
UPS
41
11
GM
71
6
HBI
61
11
VRSK
70
-3
AMGN
39
5
NEE
60
6
CAH
69
2
MCD
41
2
Financhill
Back

Akero Therapeutics Stock Predictions

10 Best Stocks to Own in 2025

Get your copy now FREE!
Buy
62

AKRO
Akero Therapeutics

Last Price:
$49.64
Seasonality Move:
22.68%

7 Day Trial

ALL ACCESS PASS

$ 7

10 stocks to buy for the next leg of this rally

Get the full list here FREE

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 86.6% based on the past 5 years of stock performance.
  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $49.65. The Score for AKRO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 86.6% based on the past 5 years of stock performance.

Akero Therapeutics Stock Rating

Buy
62
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
58.40
52-Week Low:
17.86

Prediction Charts

Market Cap:
4B
Price in USD:
49.65
Volume:
3.2M
Beta:
-0.04

Technical Analysis

SMA50:
41.67
SMA100:
41.85
SMA200:
35.37
52-Wk Change:
171.16%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 49.65 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-12 40.10 41.53 42.18 40.06
May-13 41.42 40.01 42.14 40.00
May-14 39.44 37.88 40.63 37.28
May-15 38.04 39.96 40.19 37.62
May-16 40.02 38.87 40.50 38.74
May-19 38.79 38.14 39.25 37.57
May-20 38.56 47.57 49.05 37.89
May-21 47.40 48.35 48.97 45.83
May-22 48.01 48.97 50.54 47.99
May-23 47.83 46.36 48.50 45.58
May-27 47.50 46.00 49.29 45.87
May-28 45.87 45.32 46.62 45.24
May-29 45.47 48.03 48.80 44.94
May-30 47.55 49.65 51.66 47.17

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.63 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.